We invest, acquire, and incubate category leaders.
We back founders in AI, digital assets, and healthcare with permanent capital and operator support.
View full portfolioInvestors second, founders first.
Before deploying capital, we built and operated in the markets we back. That experience shapes how we source, diligence, and support founders.
Our conviction comes from direct work, not market noise.
AI Infrastructure
Agent frameworks, robotics, and the compute layer powering autonomous systems. A market forming faster than consensus can track it.
Digital Assets
Protocol infrastructure, decentralized networks, and programmable coordination. We focus on teams building lasting value beneath the speculation.
Healthcare
Pre-IPO biotech, clinical-stage therapeutics, and longevity science across US, Hong Kong, and Australian markets. We track FDA catalysts, Phase II readouts, and the convergence of AI with drug discovery.
Invest. Acquire. Incubate.
We invest in breakout teams, acquire strategic assets, and incubate new companies. Each track compounds the others.
Invest
Minority positions in early-stage teams across our three sectors. We hold long term and add with conviction.
Acquire
Strategic acquisitions of products, teams, and businesses that strengthen our verticals and accelerate execution.
Incubate
We turn internal theses into standalone companies when we see clear market pull and operator advantage.
What we look for.
Our edge is first-hand research and operating context. We form a view early and act with discipline.
Coverage-Driven
Our research products and data indices cover every market we invest in. We publish, build tools, and generate proprietary data before we write a check.
Operator DNA
Built companies, launched tokens, ran go-to-market for 30+ projects. We evaluate founders the way founders evaluate each other: by what they have shipped.
Balance Sheet Conviction
Permanent capital with no fund lifecycle pressure. We size positions based on conviction, not allocation models, and we compound over years, not quarters.
Select investments.
*Includes investments and incubations by Pylon Partners and its principals.
"Pylon has been an important strategic partner since our launch. They sharpen our focus and get in the trenches with us to execute. Simply put, they're the best at what they do."Wei Xie, COO, NRN Agents
Latest thinking.
The Decentralized Robotics Landscape
Mapping the intersection of robotics, AI, and decentralized infrastructure. Where physical automation meets programmable coordination.
x402: The Payments Protocol for AI Agents
Breaking down the x402 protocol backed by Coinbase and Cloudflare. Why agentic payments may be the defining infrastructure layer.
Bittensor: The Intelligence Olympics
Decentralized AI infrastructure with fiat revenue at scale, enterprise contracts, and institutional capital entering.
Our Principals.
Jack Ai-Leung
Leads the firm's investment and growth activities. Formerly led token strategy for $IMX, and consumer PE investor based in HK. Host of the Supercycle podcast.
LinkedIn →
0xDith
Ex-Stripe, where he led go-to-market across the Middle East and North Africa. Fmr Proof of Play CMO (A16z). Leads deal origination, portfolio operations, and founder relationships. Identifies founders who ship product, not pitch decks.
@0xDith →
0xSammy
One of the most widely respected independent analysts in crypto AI, covering infrastructure, protocol economics, and decentralized networks. 90k+ followers on X and 7k+ subscribers to his research.
@0xSammy →






